Drug Discovery World

FEBRUARY 6, 2024

Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate. Automation is also being applied to genomics sample preparation, an area that requires particular robustness and scalability.

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

JULY 3, 2024

NM: So, what we’re interested in the Milner is basically partnering between pharma and academia. We have a big consortium agreement that, at the moment, involves 14 pharma companies. NM: I think it’s moving into primary tissue, certainly for the wet lab work that we do on the arrayed functional genomics.

Research 59

Research Big Data Gene Drugs 59

Drug Discovery World

JULY 3, 2024

NM: So, what we’re interested in the Milner is basically partnering between pharma and academia. We have a big consortium agreement that, at the moment, involves 14 pharma companies. NM: I think it’s moving into primary tissue, certainly for the wet lab work that we do on the arrayed functional genomics.

Big Data 52

Big Data Gene Nurses RNA 52

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116